A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

NCT00002140 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Mycobacterium Avium-intracellulare Infection
HIV Infections

Interventions

DRUG: Ethambutol hydrochloride
DRUG: Clarithromycin
DRUG: Azithromycin

Sponsor

Pfizer